Calidi Biotherapeutics, Inc. (CLDWW) SEC Filings — 2024
50 SEC filings for Calidi Biotherapeutics, Inc. (CLDWW) in 2024.
Filings
- Calidi Biotherapeutics Files S-1 — S-1 · Dec 12, 2024
- Calidi Biotherapeutics Files 8-K Report — 8-K · Nov 18, 2024
- Calidi Biotherapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Nov 15, 2024
- Calidi Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Calidi Biotherapeutics Files 8-K on Financials — 8-K · Nov 13, 2024
- Calidi Biotherapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Calidi Biotherapeutics Files 8-K for Equity Sales — 8-K · Oct 24, 2024
- Calidi Biotherapeutics Faces Delisting Concerns — 8-K · Oct 18, 2024
- Calidi Biotherapeutics Files 8-K: Material Agreement — 8-K · Oct 11, 2024
- Calidi Biotherapeutics Files 8-K — 8-K · Sep 30, 2024
- Calidi Biotherapeutics Files 8-K on Security Holder Vote Matters — 8-K · Sep 24, 2024
- Calidi Biotherapeutics Files 8-K — 8-K · Sep 12, 2024
- Calidi Biotherapeutics, Inc. SC 13G Filing — SC 13G · Sep 11, 2024
- Calidi Biotherapeutics Files 8-K — 8-K · Aug 22, 2024
- Calidi Biotherapeutics Appoints New CMO, Adds Director — 8-K · Aug 20, 2024
- Calidi Biotherapeutics Files 8-K on Financials — 8-K · Aug 14, 2024
- Calidi Biotherapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Calidi Biotherapeutics Files 8-K on Equity Sales — 8-K · Jul 29, 2024
- Calidi Biotherapeutics Files 8-K for Bylaws and Financials — 8-K · Jul 15, 2024
- Calidi Biotherapeutics Enters Loan Agreement — 8-K · Jul 8, 2024
- Calidi Biotherapeutics Files 8-K — 8-K · Jul 5, 2024
- Calidi Biotherapeutics Appoints New CMO, Director — 8-K · Jun 26, 2024
- Calidi Biotherapeutics Files 8-K on Shareholder Votes and Exhibits — 8-K · Jun 12, 2024
- Calidi Biotherapeutics Files 8-K with Material Agreements — 8-K · Jun 4, 2024
- Calidi Biotherapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · May 31, 2024
- Calidi Biotherapeutics Announces CFO Departure, Board Changes — 8-K · May 17, 2024
- Calidi Biotherapeutics Announces Board and Executive Changes — 8-K · May 16, 2024
- Calidi Biotherapeutics Secures $10M Private Placement — 8-K · May 15, 2024
- Calidi Biotherapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Calidi Biotherapeutics Announces Special Meeting of Stockholders on June 6, 2024 — DEF 14A · May 9, 2024
- Calidi Biotherapeutics Signs Material Definitive Agreement — 8-K · Apr 19, 2024
- Calidi Biotherapeutics Enters Material Definitive Agreement — 8-K · Apr 18, 2024
- Calidi Biotherapeutics Files S-1/A Amendment — S-1/A · Apr 15, 2024
- Calidi Biotherapeutics, Inc. Files S-1/A Amendment — S-1/A · Apr 8, 2024
- Calidi Biotherapeutics, Inc. Files Amendment to S-1 Registration Statement — S-1/A · Apr 2, 2024
- Calidi Biotherapeutics, Inc. Files S-1/A Amendment — S-1/A · Apr 1, 2024
- Calidi Biotherapeutics Files 8-K on Financials — 8-K · Mar 18, 2024
- Calidi Biotherapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 15, 2024
- Calidi Biotherapeutics Files 8-K: Agreement Termination & New Obligations — 8-K · Mar 12, 2024
- Calidi Biotherapeutics Files 8-K for Bylaw Amendments & Financials — 8-K · Mar 1, 2024
- Calidi Biotherapeutics Updates Public on Stock and Warrants — 8-K · Feb 28, 2024
- Calidi Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Calidi Biotherapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- First Trust Amends Calidi Bio Stake, Passive Investment Continues — SC 13G/A · Feb 12, 2024
- Calidi Biotherapeutics Reports Unregistered Equity Sales — 8-K · Feb 12, 2024
- Woodline Partners LP Amends Calidi Biotherapeutics Stake — SC 13G/A · Feb 12, 2024
- Polar Asset Management Discloses 2.29M Share Stake in Calidi Bio — SC 13G/A · Feb 9, 2024
- Spring Creek Capital Amends Calidi Bio Stake, Passive Investment — SC 13G/A · Feb 9, 2024
- Calidi Biotherapeutics Files 8-K on Operations & Financial Condition — 8-K · Feb 7, 2024
- Calidi Biotherapeutics Issues 1M Shares & Warrants in Unregistered Sale — 8-K · Feb 1, 2024